258 related articles for article (PubMed ID: 35609265)
1. Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma.
Guan R; Lin W; Zou J; Mei J; Wen Y; Lu L; Guo R
Cancer Control; 2022; 29():10732748221102820. PubMed ID: 35609265
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
3. Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI.
Chen FM; Du M; Qi X; Bian L; Wu D; Zhang SL; Wang J; Zhou Y; Zhu X
J Magn Reson Imaging; 2023 Jun; 57(6):1893-1905. PubMed ID: 36259347
[TBL] [Abstract][Full Text] [Related]
4. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
5. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
[TBL] [Abstract][Full Text] [Related]
7. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
8. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Gadoxetic Acid-Enhanced MRI Features for Evaluation of Vessels Encapsulating Tumor Clusters and Microvascular Invasion in Hepatocellular Carcinoma: Creating Nomograms for Risk Assessment.
Qu Q; Liu Z; Lu M; Xu L; Zhang J; Liu M; Jiang J; Gu C; Ma Q; Huang A; Zhang X; Zhang T
J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38116997
[TBL] [Abstract][Full Text] [Related]
10. Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.
Wang YY; Dong K; Wang K; Sun Y; Xing BC
Dig Liver Dis; 2023 Sep; 55(9):1288-1294. PubMed ID: 37037766
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence-Free Survival in Hepatocellular Carcinoma.
Zhang C; Ma LD; Zhang XL; Lei C; Yuan SS; Li JP; Geng ZJ; Li XM; Quan XY; Zheng C; Geng YY; Zhang J; Zheng QL; Hou J; Xie SY; Lu LH; Xie CM
J Magn Reson Imaging; 2024 Jul; 60(1):231-242. PubMed ID: 37888871
[TBL] [Abstract][Full Text] [Related]
12. Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion.
Ma M; Xie K; Jin T; Xu F
BMC Cancer; 2024 May; 24(1):617. PubMed ID: 38773511
[TBL] [Abstract][Full Text] [Related]
13. Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection.
Ren L; Chen D; Xu W; Xu T; Wei R; Suo L; Huang Y; Chen H; Liao W
BMC Cancer; 2021 Jul; 21(1):817. PubMed ID: 34266388
[TBL] [Abstract][Full Text] [Related]
14. Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma.
Dong X; Yang J; Zhang B; Li Y; Wang G; Chen J; Wei Y; Zhang H; Chen Q; Jin S; Wang L; He H; Gan M; Ji W
J Magn Reson Imaging; 2024 Jan; 59(1):108-119. PubMed ID: 37078470
[TBL] [Abstract][Full Text] [Related]
15. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
16. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
17. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.
Lu Y; Ren S; Jiang J
BMC Surg; 2023 Jan; 23(1):27. PubMed ID: 36717904
[TBL] [Abstract][Full Text] [Related]
19. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
